Is it time to convert the frequency of radiotherapy in small-cell lung cancer? - Authors' reply

Affiliations

¹ Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK. Electronic address: corinne.finn@christie.nhs.uk.
² Manchester Academic Health Science Centre Trials Co-ordination Unit, The Christie NHS Foundation Trust, UK.
³ Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.

Comment

Corinne Faivre-Finn et al. Lancet Oncol. 2017 Oct.

. 2017 Oct;18(10):e556.

doi: 10.1016/S1470-2045(17)30611-3.

¹ Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK. Electronic address: corinne.finn@christie.nhs.uk.
² Manchester Academic Health Science Centre Trials Co-ordination Unit, The Christie NHS Foundation Trust, UK.
³ Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.

No abstract available

Comment on

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team. Faivre-Finn C, et al. Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20. Lancet Oncol. 2017. PMID: 28642008 Free PMC article. Clinical Trial.
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
Zeng H, Yu J, Yuan S. Zeng H, et al. Lancet Oncol. 2017 Oct;18(10):e553. doi: 10.1016/S1470-2045(17)30580-6. Lancet Oncol. 2017. PMID: 28971812 No abstract available.
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
Mitin T, Farrell M, Holland J, Cetnar J, Thomas CR Jr. Mitin T, et al. Lancet Oncol. 2017 Oct;18(10):e554. doi: 10.1016/S1470-2045(17)30581-8. Lancet Oncol. 2017. PMID: 28971813 No abstract available.
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
Eze C, Roengvoraphoj O, Dantes M, Manapov F. Eze C, et al. Lancet Oncol. 2017 Oct;18(10):e555. doi: 10.1016/S1470-2045(17)30620-4. Lancet Oncol. 2017. PMID: 28971814 No abstract available.